Latest News

November 15, 2021

Penrose TherapeuTx Appoints Pharmaceutical Leader David Sherris, Ph.D., as President and Chief Executive Officer

May 11, 2021

Former FDA and NIH Leader Dr. Vicki Seyfert-Margolis Joins Penrose TherapeuTx Scientific Advisory Board

April 6, 2021

Penrose TherapeuTx Expands Scientific Advisory Board with Three World-Renowned Oncology Researchers

March 10, 2021

Prominent Mitochondrial Researcher Dr. Navdeep Chandel Joins Penrose TherapeuTx Scientific Advisory Board

February 11, 2021

Penrose TherapeuTx Appoints Oncology Clinical Development Veteran Bhardwaj Desai, M.D. as Chief Development Officer

Featured Articles

November 30, 2021


David Sherris Named President and CEO of Penrose TherapeuTx

May 28, 2021


Penrose TherapeuTx Closes $15.3 Million in Private Funding to Advance Novel Mitochondria Modifying Agent Platform

March 30, 2021


Penrose TherapeuTx Names Navdeep Chandel to Scientific Advisory Board

February 5, 2021


Penrose TherapeuTx Announces Mark de Souza as CEO

December 7, 2020

Crain’s Chicago Business

Cannabis CEO joins cancer startup

December 7, 2020


BioSpace Movers & Shakers